Sling-Fiber Preservation POEM vs. Conventional POEM for Reducing Post-POEM GERD
SFP-POEM
1 other identifier
interventional
120
1 country
1
Brief Summary
Peroral endoscopic myotomy (POEM) is an effective, minimally invasive treatment for achalasia, offering excellent rates of symptom relief. However, a significant drawback is the high incidence of gastroesophageal reflux disease (GERD) following the procedure. One proposed technical modification, the selective preservation of the sling fibers during gastric myotomy (SFP-POEM), may reduce this risk without compromising efficacy as compared to a conventional POEM procedure, which includes myotomy of the sling fibers. In this study, adults with achalasia will be randomly assigned to receive one of the two POEM technical approaches. Researchers will monitor whether preserving sling fibers reduces the rates of reflux esophagitis (classified as Los Angeles Grade B or higher) on follow-up endoscopy. Participants will be followed for up to 1 year after the procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 10, 2025
CompletedFirst Posted
Study publicly available on registry
September 17, 2025
CompletedStudy Start
First participant enrolled
December 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2028
October 22, 2025
October 1, 2025
2 years
September 10, 2025
October 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of Significant Reflux Esophagitis (Los Angeles Grade B or Higher)
Reflux esophagitis will be assessed by upper endoscopy (EGD) at 3 months post-POEM. Grading will be based on the Los Angeles (LA) Classification. Significant reflux is defined as LA Grade B or higher.
3 months post-procedure
Secondary Outcomes (6)
Esophageal Acid Exposure
3 months post-procedure
Symptomatic Gastroesophageal Reflux (GerdQ Score)
3, 6, 12 months post-procedure
Proton Pump Inhibitor (PPI) Use
3, 6, 12 months post-procedure
Clinical Success (Eckardt Symptom Score ≤ 3)
3, 6 and 12 months post-procedure
Technical Success
During procedure
- +1 more secondary outcomes
Study Arms (2)
Conventional POEM
ACTIVE COMPARATORParticipants in this arm will undergo standard peroral endoscopic myotomy (POEM), including myotomy of circular and sling muscle fibers at the gastric side.
Sling Fiber-Preservation POEM
EXPERIMENTALParticipants in this arm will undergo posterior POEM with selective preservation of the gastric sling fibers. Myotomy is performed to the right of the second penetrating vessel to spare the sling fibers. The double scope technique will be employed to confirm that the tunnel ends on the lesser curve, which confirms sparing of the sling fibers.
Interventions
Standard posterior POEM with full-thickness myotomy, including both circular and gastric sling muscle fibers.
Posterior POEM with selective preservation of gastric sling fibers by limiting myotomy to the right of the second penetrating vessel.
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years
- Diagnosis of achalasia (Type I-III) per Chicago Classification v3.0
- Deemed appropriate candidates for POEM
- Ability to provide informed consent
You may not qualify if:
- Spastic motility disorders other than achalasia type I-III (e.g. diffuse esophageal spasm, jackhammer esophagus, EGJ outflow obstruction)
- Sigmoid esophagus
- Prior surgical myotomy (e.g., Heller myotomy)
- Contraindications to endoscopy or general anesthesia
- Pregnancy or actively breastfeeding
- Significant cardiopulmonary comorbidities that preclude safe endoscopic intervention
- Coagulopathy or portal hypertension
- Unwillingness or inability to complete follow-up assessments
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of California, Irvinelead
- Hoag Memorial Hospital Presbyteriancollaborator
- University of Ottawacollaborator
- Vancouver General Hospitalcollaborator
- Cedars-Sinai Medical Centercollaborator
Study Sites (1)
University of California, Irvine - UCI Medical Center
Orange, California, 92868, United States
Related Publications (4)
Nabi Z, Chandran V, Basha J, Ramchandani M, Inavolu P, Kalpala R, Goud R, Jagtap N, Darisetty S, Gupta R, Tandan M, Lakhtakia S, Kotla R, Devarasetty R, Rao GV, Reddy DN. Conventional versus oblique fiber-sparing endoscopic myotomy for achalasia cardia: a randomized controlled trial (with videos). Gastrointest Endosc. 2024 Jan;99(1):1-9. doi: 10.1016/j.gie.2023.08.007. Epub 2023 Aug 19.
PMID: 37598863BACKGROUNDFujiyoshi Y, Fujiyoshi MRA, Khalaf K, May GR, Teshima CW. Sling fiber preservation during POEM reduces incidence of postoperative reflux symptoms. Dis Esophagus. 2025 Jan 7;38(1):doae097. doi: 10.1093/dote/doae097.
PMID: 39586589BACKGROUNDTanaka S, Toyonaga T, Kawara F, Watanabe D, Hoshi N, Abe H, Ariyoshi R, Ohara Y, Takao T, Morita Y, Umegaki E, Kodama Y. Novel per-oral endoscopic myotomy method preserving oblique muscle using two penetrating vessels as anatomic landmarks reduces postoperative gastroesophageal reflux. J Gastroenterol Hepatol. 2019 Dec;34(12):2158-2163. doi: 10.1111/jgh.14814. Epub 2019 Aug 23.
PMID: 31373050BACKGROUNDShiwaku H, Inoue H, Shiwaku A, Okada H, Hasegawa S. Safety and effectiveness of sling fiber preservation POEM to reduce severe post-procedural erosive esophagitis. Surg Endosc. 2022 Jun;36(6):4255-4264. doi: 10.1007/s00464-021-08763-w. Epub 2021 Oct 29.
PMID: 34716481BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jason Samarasena, MD, MBA
University of California, Irvine
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Participants are blinded to the intervention group. Endoscopists performing the procedure cannot be blinded.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Clinical Professor
Study Record Dates
First Submitted
September 10, 2025
First Posted
September 17, 2025
Study Start
December 1, 2025
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
January 1, 2028
Last Updated
October 22, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared outside the study team. The current protocol does not include provisions for public or external data sharing.